Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Multiple Sclerosis

  Free Subscription


Articles published in J Neurol Sci

Retrieve available abstracts of 138 articles:
HTML format
Text format



Single Articles


    March 2010
  1. SCOTT TF , Schramke CJ
    Poor recovery after the first two attacks of multiple sclerosis is associated with poor outcome five years later.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available


  2. KINGWELL E , Leung AL, Roger E, Duquette P, et al
    Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  3. MEHTA BK
    New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available


    January 2010
  4. MATSUSHITA T , Isobe N, Piao H, Matsuoka T, et al
    Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available


  5. RAMAGOPALAN SV , Dyment DA, Guimond C, Orton SM, et al
    Childhood cow's milk allergy and the risk of multiple sclerosis: A population based study.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available


  6. LIGGETT T , Melnikov A, Tilwalli S, Yi Q, et al
    Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available


  7. WEIKERT M , Motl RW, Suh Y, McAuley E, et al
    Accelerometry in persons with multiple sclerosis: Measurement of physical activity or walking mobility?
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available


  8. QIU W , Raven S, Wu JS, Carroll WM, et al
    Wedge-shaped medullary lesions in multiple sclerosis.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  9. BERGER T
    Current therapeutic recommendations in multiple sclerosis.
    J Neurol Sci. 2009;287S1:S37-S45.
    PubMed     Text format     Related articles    Abstract available


  10. STUVE O
    Knowns and unknowns in the future of multiple sclerosis treatment.
    J Neurol Sci. 2009;287S1:S30-S36.
    PubMed     Text format     Related articles    Abstract available


  11. ZIPP F
    A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes.
    J Neurol Sci. 2009;287S1:S24-S29.
    PubMed     Text format     Related articles    Abstract available


  12. LIBLAU R
    Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
    J Neurol Sci. 2009;287S1:S17-S23.
    PubMed     Text format     Related articles    Abstract available


  13. ZWIBEL H
    Health and quality of life in patients with relapsing multiple sclerosis: making the intangible tangible.
    J Neurol Sci. 2009;287S1:S11-S16.
    PubMed     Text format     Related articles    Abstract available


  14. BOYKO A , Alain Gabbai A
    Recent advances in multiple sclerosis: challenging paradigms.
    J Neurol Sci. 2009;287 Suppl 1:S1.
    PubMed     Text format     Related articles   


    November 2009
  15. GLANZ BI , Healy BC, Rintell DJ, Jaffin SK, et al
    The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  16. GOLD SM , Schulz H, Stein H, Solf K, et al
    Responsiveness of patient-based and external rating scales in multiple sclerosis: Head-to-head comparison in three clinical settings.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  17. YAMOUT B , Itani S, Hourany R, Sibaii AM, et al
    The effect of war stress on multiple sclerosis exacerbations and radiological disease activity.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  18. WU JS , Qiu W, Castley A, James I, et al
    Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  19. DI PAULI F , Gredler V, Kuenz B, Lutterotti A, et al
    Features of intrathecal immunoglobulins in patients with multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  20. FLAVIA M , Stampatori C, Zanotti D, Parrinello G, et al
    Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  21. SIOKA C , Kyritsis AP, Fotopoulos A
    Multiple sclerosis, osteoporosis, and vitamin D.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  22. PALACE J
    Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  23. SADOVNICK AD
    Charcot Lecture: The natural history of multiple sclerosis and gender.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  24. DE SANTI L , Annunziata P, Sessa E, Bramanti P, et al
    Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  25. VUKUSIC S , Ionescu I, El-Etr M, Schumacher M, et al
    The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: Rationale, objectives and state of advancement.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  26. FAZEKAS F , Enzinger C, Wallner-Blazek M, Ropele S, et al
    Gender differences in MRI studies on multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  27. JEAN-GILLES L , Feng S, Tench CR, Chapman V, et al
    Plasma endocannabinoid levels in multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  28. NOCITI V , Fasano A, Bentivoglio AR, Frisullo G, et al
    Tourettism in Multiple Sclerosis: A case report.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  29. DEBOUVERIE M
    Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  30. VAMOS E , Pardutz A, Klivenyi P, Toldi J, et al
    The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
    J Neurol Sci. 2009;283.
    PubMed     Text format     Related articles    Abstract available


  31. TINTORE M , Arrambide G
    Early onset multiple sclerosis: The role of gender.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  32. PUGLIATTI M , Cossu P, Sotgiu S, Rosati G, et al
    Clustering of multiple sclerosis, age of onset and gender in Sardinia.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  33. EIKELENBOOM MJ , Killestein J, Kragt JJ, Uitdehaag BM, et al
    Gender differences in multiple sclerosis: Cytokines and vitamin D.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  34. TROJANO M , Pellegrini F, Paolicelli D, Fuiani A, et al
    Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  35. FROHMAN EM , Dwyer MG, Frohman T, Cox JL, et al
    Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
    J Neurol Sci. 2009;282.
    PubMed     Text format     Related articles    Abstract available


  36. GEURTS JJ , Stys PK, Minagar A, Amor S, et al
    Gray matter pathology in (chronic) MS: modern views on an early observation.
    J Neurol Sci. 2009;282.
    PubMed     Text format     Related articles    Abstract available


  37. RAMASAMY DP , Benedict RH, Cox JL, Fritz D, et al
    Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    J Neurol Sci. 2009;282.
    PubMed     Text format     Related articles    Abstract available


  38. PIRKO I , Johnson AJ, Lohrey AK, Chen Y, et al
    Deep gray matter T2 hypointensity correlates with disability in a murine model of MS.
    J Neurol Sci. 2009;282.
    PubMed     Text format     Related articles    Abstract available


  39. RUDICK RA , Lee JC, Nakamura K, Fisher E, et al
    Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
    J Neurol Sci. 2009;282.
    PubMed     Text format     Related articles    Abstract available


  40. ACHIRON A , Gurevich M
    Gender effects in relapsing-remitting multiple sclerosis: Correlation between clinical variables and gene expression molecular pathways.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  41. MOTL RW , Schwartz CE, Vollmer T
    Continued validation of the Symptom Inventory in multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  42. PUTZKI N , Yaldizli O, Tettenborn B, Diener HC, et al
    Multiple sclerosis associated fatigue during natalizumab treatment.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  43. MYHR KM
    Vitamin D treatment in multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  44. GOLD SM , Voskuhl RR
    Estrogen treatment in multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  45. CABRE P
    Environmental changes and epidemiology of multiple sclerosis in the French West Indies.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  46. BATTAGLINI M , Giorgio A, De Stefano N
    Response to the letter "Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis" by Bendfeldt et al.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles   


  47. BENDFELDT K , Kappos L, Radue EW, Borgwardt SJ, et al
    Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles   


    May 2009
  48. PERRON H , Bernard C, Bertrand JB, Lang AB, et al
    Endogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  49. JARIUS S , Eichhorn P, Jacobi C, Wildemann B, et al
    The intrathecal, polyspecific antiviral immune response: Specific for MS or a general marker of CNS autoimmunity?
    J Neurol Sci. 2009;280.
    PubMed     Text format     Related articles    Abstract available


  50. GAUTHIER SA , Glanz BI, Mandel M, Tsagkaropoulos A, et al
    Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  51. ALONSO A , Clark CJ
    Oral contraceptives and the risk of multiple sclerosis: A review of the epidemiologic evidence.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  52. TOMASSINI V , Pozzilli C
    Sex hormones, brain damage and clinical course of Multiple Sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  53. KNUDSEN GP
    Gender bias in autoimmune diseases X chromosome inactivation in women with multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles   


    April 2009
  54. BAGNATO F , Yao B, Cantor F, Merkle H, et al
    Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: Observations from a post-mortem 3 Tesla imaging study.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  55. DWYER M , Bergsland N, Hussein S, Durfee J, et al
    A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  56. KREFT KL , Mellema SJ, Hintzen RQ
    Spinal cord involvement in Balo's concentric sclerosis.
    J Neurol Sci. 2009;279.
    PubMed     Text format     Related articles    Abstract available


  57. POHL D
    Epstein-Barr virus and multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  58. ZIVADINOV R , Minagar A
    Evidence for gray matter pathology in multiple sclerosis: A neuroimaging approach.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  59. SMITH AM , Walker LA, Freedman MS, Demeulemeester C, et al
    fMRI investigation of disinhibition in cognitively impaired patients with multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  60. WATANABE A , Matsushita T, Doi H, Matsuoka T, et al
    Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  61. COSTELLO F , Hodge W, Pan YI, Freedman M, et al
    Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  62. HOLTZER R , Foley F
    The relationship between subjective reports of fatigue and executive control in Multiple Sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  63. BATTAGLINI M , Giorgio A, Stromillo ML, Bartolozzi ML, et al
    Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  64. MACKENZIE J , Tajouri L, Szvetko A, Weth V, et al
    Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  65. CARAMANOS Z , Dimaio S, Narayanan S, Lapierre Y, et al
    (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  66. ISHIZU T , Kira JI, Osoegawa M, Fukazawa T, et al
    Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  67. CHARD D , Miller D
    Grey matter pathology in clinically early multiple sclerosis: Evidence from magnetic resonance imaging.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  68. TINTORE M
    New options for early treatment of multiple sclerosis.
    J Neurol Sci. 2009;277 Suppl 1:S9-S11.
    PubMed     Text format     Related articles    Abstract available


  69. COHEN JA
    The future of multiple sclerosis treatment.
    J Neurol Sci. 2009;277 Suppl 1:S55-61.
    PubMed     Text format     Related articles    Abstract available


  70. LE PAGE E , Edan G
    Long-term experience with induction treatment regimens in multiple sclerosis.
    J Neurol Sci. 2009;277 Suppl 1:S46-9.
    PubMed     Text format     Related articles    Abstract available


  71. RIECKMANN P
    Concepts of induction and escalation therapy in multiple sclerosis.
    J Neurol Sci. 2009;277 Suppl 1:S42-5.
    PubMed     Text format     Related articles    Abstract available


  72. ZIEMSSEN T
    Multiple sclerosis beyond EDSS: depression and fatigue.
    J Neurol Sci. 2009;277 Suppl 1:S37-41.
    PubMed     Text format     Related articles    Abstract available


  73. MURRAY TJ
    The history of multiple sclerosis: the changing frame of the disease over the centuries.
    J Neurol Sci. 2009;277 Suppl 1:S3-8.
    PubMed     Text format     Related articles    Abstract available


  74. KHAN O
    What can be learned from open direct comparative trials in multiple sclerosis?
    J Neurol Sci. 2009;277 Suppl 1:S25-8.
    PubMed     Text format     Related articles    Abstract available


  75. YONG VW
    Prospects of repair in multiple sclerosis.
    J Neurol Sci. 2009;277 Suppl 1:S16-8.
    PubMed     Text format     Related articles    Abstract available


  76. FAZEKAS F , Kieseier BC
    Translating new insights into treatment optimisation in multiple sclerosis.
    J Neurol Sci. 2009;277 Suppl 1:S1-2.
    PubMed     Text format     Related articles   



  77. Translating new insights into treatment optimisation in multiple sclerosis. Proceedings of the Seventh International Symposium on Multiple Sclerosis. May 23-24, 2008. Vienna, Austria.
    J Neurol Sci. 2009;277 Suppl 1:S1-61.
    PubMed     Text format     Related articles   


  78. BOGGILD M
    Immunosuppression followed by immunomodulation.
    J Neurol Sci. 2009;277 Suppl 1:S50-4.
    PubMed     Text format     Related articles    Abstract available


  79. CAON C
    Maximising therapeutic outcomes in patients failing on current therapy.
    J Neurol Sci. 2009;277 Suppl 1:S33-6.
    PubMed     Text format     Related articles    Abstract available


  80. BERTOLOTTO A
    Implications of neutralising antibodies on therapeutic efficacy.
    J Neurol Sci. 2009;277 Suppl 1:S29-32.
    PubMed     Text format     Related articles    Abstract available


  81. ACHIRON A , Fredrikson S
    Lessons from randomised direct comparative trials.
    J Neurol Sci. 2009;277 Suppl 1:S19-24.
    PubMed     Text format     Related articles    Abstract available


  82. MOREAU T
    Link of the mechanisms of action of glatiramer acetate to its long-term clinical data.
    J Neurol Sci. 2009;277 Suppl 1:S12-5.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  83. PANDIT A , Vadnal J, Houston S, Freeman E, et al
    Impaired regulation of electron transport chain subunit genes by nuclear respiratory factor 2 in multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  84. VARGA AW , Johnson G, Babb JS, Herbert J, et al
    White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  85. SIRITHO S , Freedman MS
    The prognostic significance of cerebrospinal fluid in multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  86. STANKIEWICZ JM , Neema M, Alsop DC, Healy BC, et al
    Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  87. HORAKOVA D , Dwyer MG, Havrdova E, Cox JL, et al
    Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis A 5-year longitudinal study.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  88. TAO G , Datta S, He R, Nelson F, et al
    Deep gray matter atrophy in multiple sclerosis: A tensor based morphometry.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  89. ESTEBAN FJ , Sepulcre J, de Miras JR, Navas J, et al
    Fractal dimension analysis of grey matter in multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  90. SASTRE-GARRIGA J , Arevalo MJ, Renom M, Alonso J, et al
    Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  91. VAVASOUR IM , Laule C, Li DK, Oger J, et al
    Longitudinal changes in myelin water fraction in two MS patients with active disease.
    J Neurol Sci. 2009;276.
    PubMed     Text format     Related articles    Abstract available


  92. ZAMBONI P , Menegatti E, Galeotti R, Malagoni AM, et al
    The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  93. PACHNER AR , Steiner I
    The multiple sclerosis severity score (MSSS) predicts disease severity over time.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


  94. BENAMER HT , Ahmed ES, Al-Din AS, Grosset DG, et al
    Frequency and clinical patterns of multiple sclerosis in Arab countries: A systematic review.
    J Neurol Sci. 2009.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  95. HEALY BC , Hayden DL, Sampat MP, Bakshi R, et al
    Unbiased treatment effect estimates by modeling the disease process of multiple sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  96. DE SANTI L , Cantalupo L, Tassi M, Raspadori D, et al
    Higher expression of BDNF receptor gp145trkB is associated with lower apoptosis intensity in T cell lines in multiple sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


    October 2008
  97. FIELDING J , Kilpatrick T, Millist L, White O, et al
    Multiple sclerosis: Cognition and saccadic eye movements.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  98. KALANIE H , Kholghie Y, Shamsai GR, Ghorbani M, et al
    Opticospinal multiple sclerosis in Iran.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  99. ALTINTAS A , Saruhan-Direskeneli G, Benbir G, Demir M, et al
    The role of osteopontin: A shared pathway in the pathogenesis of multiple sclerosis and osteoporosis?
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  100. COHEN BA , Oger J, Gagnon A, Giovannoni G, et al
    The implications of immunogenicity for protein-based multiple sclerosis therapies.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  101. D'SOUZA M , Kappos L, Czaplinski A
    Reconsidering clinical outcomes in Multiple Sclerosis: Relapses, impairment, disability and beyond.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  102. HAREL Y , Appleboim N, Lavie M, Achiron A, et al
    Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  103. YANG J , Rostami A, Zhang GX
    Cellular remyelinating therapy in multiple sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  104. HURWITZ BJ
    Important sources of variability in clinical studies of neutralizing antibodies against interferon beta.
    J Neurol Sci. 2008;272.
    PubMed     Text format     Related articles    Abstract available


  105. MILLER A , Avidan N, Tzunz-Henig N, Glass-Marmor L, et al
    Translation towards personalized medicine in Multiple Sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  106. GIORDANO A , Mattarozzi K, Pucci E, Leone M, et al
    Participation in medical decision-making: Attitudes of Italians with multiple sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  107. REGENOLD WT , Phatak P, Makley MJ, Stone RD, et al
    Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  108. STEINMAN L
    New targets for treatment of multiple sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


    August 2008
  109. MEINL E , Krumbholz M, Derfuss T, Junker A, et al
    Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  110. HOHLFELD R , Meinl E, Dornmair K
    B- and T-cell responses in multiple sclerosis: Novel approaches offer new insights.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  111. O'KEEFFE J , Gately CM, Counihan T, Hennessy M, et al
    T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  112. HAMANN I , Zipp F, Infante-Duarte C
    Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  113. MARTINEZ-RODRIGUEZ JE , Munteis E, Carreno M, Blanco Y, et al
    Cannabis use in Spanish patients with multiple sclerosis: Fulfilment of patients' expectations?
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  114. KO MW , Tamhankar MA, Volpe NJ, Porter D, et al
    Acute promyelocytic leukemic involvement of the optic nerves following mitoxantrone treatment for multiple sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  115. GONSETTE RE
    Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


  116. NOCITI V , Batocchi AP, Bartalini S, Caggiula M, et al
    Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis.
    J Neurol Sci. 2008.
    PubMed     Text format     Related articles    Abstract available


    July 2008
  117. FERREIRA VASCONCELOS CC , Miranda Santos CM, Papais Alvarenga M, Camargo SM, et al
    The reliability of specific primary progressive MS criteria in an ethnically diverse population.
    J Neurol Sci. 2008;270.
    PubMed     Text format     Related articles    Abstract available


  118. DAVENPORT RJ , Munday JR
    Blocking alpha4-integrins - A small molecule approach to treatment of multiple sclerosis.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


    June 2008
  119. TOUIL T , Ciric B, Ventura E, Shindler KS, et al
    Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


  120. RIST JM , Franklin RJ
    Taking ageing into account in remyelination-based therapies for multiple sclerosis.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


    May 2008
  121. HAIMAN G , Pratt H, Miller A
    Brain responses to verbal stimuli among multiple sclerosis patients with pseudobulbar affect.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


  122. LASSMANN H
    Mechanisms of inflammation induced tissue injury in multiple sclerosis.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


  123. KAPOOR R
    Sodium channel blockers and neuroprotection in multiple sclerosis using lamotrigine.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


    April 2008
  124. POTAGAS C , Giogkaraki E, Koutsis G, Mandellos D, et al
    Cognitive impairment in different MS subtypes and clinically isolated syndromes.
    J Neurol Sci. 2008;267.
    PubMed     Text format     Related articles    Abstract available


  125. STOJKOV D , Lavrnja I, Pekovic S, Dacic S, et al
    Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
    J Neurol Sci. 2008;267.
    PubMed     Text format     Related articles    Abstract available


    March 2008
  126. YAMOUT B , Barada W, Tohme RA, Mehio-Sibai A, et al
    Clinical characteristics of multiple sclerosis in Lebanon.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


  127. GELLEIN K , Skogholt JH, Aaseth J, Thoresen GB, et al
    Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease.
    J Neurol Sci. 2008;266.
    PubMed     Text format     Related articles    Abstract available


  128. DELUCA J , Genova HM, Hillary FG, Wylie G, et al
    Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


    February 2008
  129. YTTERBERG C , Johansson S, Holmqvist LW, Koch LV, et al
    Longitudinal variations and predictors of increased perceived impact of multiple sclerosis, a two-year study.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


  130. TURABELIDZE G , Schootman M, Zhu BP, Malone JL, et al
    Multiple sclerosis prevalence and possible lead exposure.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


  131. PALACE J
    Neuroprotection and repair.
    J Neurol Sci. 2008;265.
    PubMed     Text format     Related articles    Abstract available


  132. HOMMES OR
    Can we pass from the experimental to the clinical phase in MS stem cell research?
    J Neurol Sci. 2008;265.
    PubMed     Text format     Related articles    Abstract available


  133. SCOLDING N , Marks D, Rice C
    Autologous mesenchymal bone marrow stem cells: practical considerations.
    J Neurol Sci. 2008;265.
    PubMed     Text format     Related articles    Abstract available


  134. BERGAMASCHI R , Crivelli P, Rezzani C, Patti F, et al
    The DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles    Abstract available


  135. CASTELLANO V , White LJ
    Serum brain-derived neurotrophic factor response to aerobic exercise in multiple sclerosis.
    J Neurol Sci. 2008;.
    PubMed     Text format     Related articles   


    January 2008
  136. HOUFF S , Berger JR
    Reply to "'Thinking without thinking' about natalizumab and PML".
    J Neurol Sci. 2008;264.
    PubMed     Text format     Related articles   


  137. EGGERT M , Goertsches R, Seeck U, Dilk S, et al
    Changes in the activation level of NF-kappa B in lymphocytes of MS patients during glucocorticoid pulse therapy.
    J Neurol Sci. 2008;264.
    PubMed     Text format     Related articles    Abstract available


    December 2007
  138. ARIAS M , Constela IR, Iglesias S, Arias-Rivas S, et al
    The autoscopic phenomena in neurological clinic: a study of two cases.
    J Neurol Sci. 2007;263.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.

   Design: